|
|
||||||||
Bosch Institute, School of Medical Sciences, University of Sydney, Sydney, Australia
Submitted 24 April 2007 ; accepted in final form 12 June 2007
Duchenne muscular dystrophy (DMD) is caused by deficiency of the cytoskeletal protein dystrophin. Oxidative stress is thought to contribute to the skeletal muscle damage in DMD; however, little is known about the role of oxidative damage in the pathogenesis of the heart failure that occurs in DMD patients. The dystrophin-deficient (mdx) mouse is an animal model of DMD that also lacks dystrophin. The current study investigates the role of the antioxidant N-acetylcysteine (NAC) on mdx cardiomyocyte function, Ca2+ handling, and the cardiac inflammatory response. Treated mice received 1% NAC in their drinking water for 6 wk. NAC had no effect on wild-type (WT) mice. Immunohistochemistry experiments revealed that mdx mice had increased dihydroethidine (DHE) staining, an indicator of superoxide production; NAC-treatment reduced DHE staining in mdx hearts. NAC treatment attenuated abnormalities in mdx cardiomyocyte Ca2+ handling. Mdx cardiomyocytes had decreased fractional shortening and decreased Ca2+ sensitivity; NAC treatment returned mdx fractional shortening to WT values but did not affect the Ca2+ sensitivity. Immunohistochemistry experiments revealed that mdx hearts had increased levels of collagen type III and the macrophage-specific protein, CD68; NAC-treatment returned collagen type III and CD68 expression close to WT values. Finally, mdx hearts had increased NADPH oxidase activity, suggesting it could be a possible source of increased reactive oxygen species in mdx mice. This study is the first to demonstrate that oxidative damage may be involved in the pathogenesis of the heart failure that occurs in mdx mice. Therapies designed to reduce oxidative damage might be beneficial to DMD patients with heart failure.
calcium handling; dilated cardiomyopathy; Duchenne muscular dystrophy
This article has been cited by other articles:
![]() |
K. N. Hor, J. Wansapura, L. W. Markham, W. Mazur, L. H. Cripe, R. Fleck, D. W. Benson, and W. M. Gottliebson Circumferential strain analysis identifies strata of cardiomyopathy in duchenne muscular dystrophy a cardiac magnetic resonance tagging study. J. Am. Coll. Cardiol., April 7, 2009; 53(14): 1204 - 1210. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Abramowitz and L. Birnbaumer Physiology and pathophysiology of canonical transient receptor potential channels FASEB J, February 1, 2009; 23(2): 297 - 328. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Buyse, G. Van der Mieren, M. Erb, J. D'hooge, P. Herijgers, E. Verbeken, A. Jara, A. Van Den Bergh, L. Mertens, I. Courdier-Fruh, et al. Long-term blinded placebo-controlled study of SNT-MC17/idebenone in the dystrophin deficient mdx mouse: cardiac protection and improved exercise performance Eur. Heart J., January 1, 2009; 30(1): 116 - 124. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. L. Gervasio, N. P. Whitehead, E. W. Yeung, W. D. Phillips, and D. G. Allen TRPC1 binds to caveolin-3 and is regulated by Src kinase - role in Duchenne muscular dystrophy J. Cell Sci., July 1, 2008; 121(13): 2246 - 2255. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. P. Whitehead, C. Pham, O. L. Gervasio, and D. G. Allen N-Acetylcysteine ameliorates skeletal muscle pathophysiology in mdx mice J. Physiol., April 1, 2008; 586(7): 2003 - 2014. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Jung, A. S. Martins, E. Niggli, and N. Shirokova Dystrophic cardiomyopathy: amplification of cellular damage by Ca2+ signalling and reactive oxygen species-generating pathways Cardiovasc Res, March 1, 2008; 77(4): 766 - 773. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |